Located on the main floor of the Feist-Weiller Cancer Center, the new Storment Technology Center will provide patients with online access to important information related to their cancer diagnosis and treatment.
8 RESEARCH CENTERS
Led by Renowned Scientists and Dedicated to Advancing Scientific Discovery
CENTERS OF EXCELLENCE
A select number of academic programs earn the designation as a Center of Excellence by the Louisiana Board of Regents and must demonstrate statewide leadership in their area of focus and a commitment to building on their respective strengths by advancing knowledge and skills to create better opportunities for improving the quality of life of Louisiana residents. Designated centers share being a hallmark of the institution with a strong performance record, concentration in a clearly defined area relevant to the state’s needs, a range of academic, training and research opportunities, and engagement with the greater community to address current issues. LSU Health Shreveport is home to four designated Centers of Research Excellence.
Feist-Weiller Cancer Center
The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer.
Center of Excellence for Arthritis and Rheumatology
The Center engages in a multidisciplinary clinical, research and education mission to provide patients with cutting-edge care, advance the science of inflammatory and immunology diseases and to educate physicians.
Center for Cardiovascular Diseases and Sciences
The Center's mission is to advance the understanding of cardiovascular disease and translational research while developing future generations of basic and clinical science investigators.
Center for Emerging Viral Threats
The Center intersects critical public health needs with timely delivery of clinical and vaccine trials, testing, key SARS-CoV2 and other pathogen clinical diagnosis, community education, and training scientists, physicians and health work force.
TEACH • HEAL • DISCOVER
Center for Brain Health
The Center for Brain Health expands neuroscience-related education, provides comprehensive care for brain disorders, and attracts young specialists and pioneering clinical trials to North Louisiana, and competes for large scale research funding.
Louisiana Addiction Research Center
LARC is committed to increasing knowledge and advancing research related to Substance Use Disorders to create a better quality of life for the citizens of our area.
Center of Academic Excellence for Patient Centered Rehabilitation
The School of Allied Health Professions' Center (CAE-PaCeR) will establish an infrastructure to bring the relevant academic, research, and clinical programs of the School into alignment for clinical learning, innovation, and collaboration.
Centers of Biomedical Research Excellence
In addition to the six Louisiana Board of Regents and LSU Board of Supervisors approved Centers, LSU Health Shreveport has two National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE). The Centers of Biomedical Research Excellence (COBRE) awards support the establishment and development of innovative, state-of-the-art biomedical and behavioral research centers at institutions in IDeA-eligible states through awards for three sequential five-year phases.
Center for Applied Immunology and Pathological Processes
The Center for Applied Immunology and Pathological Processes, directed by Dr. Andrew Yurochko, was established In 2021, supported by a five year, $10.5 million grant from the NIH.
Center for Redox Biology and Cardiovascular Disease
The Center for Redox Biology and Cardiovascular Disease, directed by Dr. Chris Kevil, was established in 2018 and is supported by a five-year, $10.5 million NIH COBRE grant.
Our Centers are actively engaged in educating the community,
training future scientists and advancing research through active collaborations.
Latest Research Centers News
LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.
“BRAID is more than just a conference, it’s a vibrant ecosystem of ideas fostering innovation among students, scientists and clinicians,” said Wayne Nix, chief innovation officer at LSUHS. “We celebrate the great minds of academia and industry brought together for a collaborative effort from all of our partners."
Louisiana Economic Development - LSU Health Shreveport scientists have discovered a promising new treatment for prostate cancer and developed a playbook detailing how to track viral variants in underserved areas.
Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.
Researchers from academic institutions in Louisiana, Mississippi and Georgia have partnered to publish a playbook detailing their model developed for establishing collaborative, community-centered infectious diseases surveillance programs committed to improving equity in genomic sequencing.
Since July 2021, the group has received grants funded for a total of $5.5 Million and had papers published in or accepted to several prestigious journals.
The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.
LSUHS has partnered with The Michael J. Fox Foundation for Parkinson’s Research to become one of five sites participating in the Black and African American Connections to Parkinson’s Disease study.
Shreveport Times - Dr. Wayne Orr, Professor and Director of the Center for Cardiovascular Diseases and Sciences said, "the Center is a group of faculty members across multiple departments who work together to build a nationally competitive research group here in Shreveport."
Earlier this week, CCDS hosted the 2nd Annual Feist Cardiovascular Research Symposium. The symposium concluded with a poster session and awards presentation.
LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.
The Louisiana Board of Regents has supported full five-year approval for the Louisiana Addiction Research Center (LARC) and Center for Emerging Viral Threats (CEVT), with the CEVT continuing to be a designated Center of Research Excellence. The Board of Regents approval follows unanimous approval of both centers by the LSU Board of Supervisors earlier this year. Both centers were previously granted provisional approval and applied for full center approval earlier this year.
The Center of Excellence for Emerging Viral Threats’ (CEVT) Viral Genomics and Surveillance Lab has surpassed uploading its’ 15,000th sequence to GISAID (Global Initiative on Sharing Influenza Data). The LSU Health Shreveport CEVT team has worked tirelessly since early in the COVID-19 pandemic to sequence and track variants of SAR-CoV-2, the virus that causes the COVID-19 disease.
A massive new study spotlights the toll methamphetamine use may take on heart health, suggesting men, people with kidney disease and those with high blood pressure are especially at risk. While researchers don't fully understand how meth use increases the risk for heart problems, they do know it creates a lot of stress on the body, shared Dr. Chris Kevil, LSUHS Vice Chancellor for Research.